Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trials
Linda Jones(Craig H Neilsen Foundation), John D. Steeves(University of British Columbia), Keith E. Tansey(Jackson Memorial Hospital), James D. Guest(University of Miami), Giorgio Scivoletto(Fondazione Santa Lucia), Daniel P. Lammertse(Craig Hospital), Laura Krisa(Thomas Jefferson University), Andrew R. Blight(Acorda Therapeutics (United States)), Lyn B. Jakeman(National Institutes of Health), Ralph J. Marino(Icahn School of Medicine at Mount Sinai), Tracey Wheeler(Craig H Neilsen Foundation), M.J. Mulcahey(Thomas Jefferson University), Benjamin E. Leiby(Thomas Jefferson University), Jane Hseih(Parkwood Institute), José Zariffa(University of Toronto), Edelle C. Field‐Fote(Georgia Institute of Technology), Jan M. Schwab(The Ohio State University Wexner Medical Center), Naomi Kleitman, Anne M. Bryden(Case Western Reserve University), Armin Curt(Universitätsklinik Balgrist), Sukhvinder Kalsi‐Ryan(University Health Network), David S. Tulsky(University of Delaware), Wirth Ed(Atara Biotherapeutics (United States)), Kim D. Anderson(University of California, Irvine), Michael S. Beattie(San Francisco General Hospital)
Cited by 44
Related Papers
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
N‐methyl‐<scp>D</scp>‐aspartate receptor antibodies in herpes simplex encephalitis
|Annals of Neurology|2012|414
Hypoxia-inducible factor–dependent induction of netrin-1 dampens inflammation caused by hypoxia
|Nature Immunology|2009|403
The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar
|Molecular and Cellular Neuroscience|2003|401